Caphorn is now part of Anaxago Group to become a leader in alternative investment.

Acticor

Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.

https://fr.acticor-biotech.com/

Other Companies in our Portfolio